1.
Melatonin as a Neuroprotective Agent in the Rodent Models of Parkinson's Disease: Is it All Set to Irrefutable Clinical Translation?
Singhal NK, Srivastava G, Agrawal S, Jain SK, Singh MP.
Mol Neurobiol. 2011 Dec 24. [Epub ahead of print]
PMID: 22198804 [PubMed - as supplied by publisher]
2.
Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.
Soreq L, Ben-Shaul Y, Israel Z, Bergman H, Soreq H.
Neurobiol Dis. 2011 Dec 16. [Epub ahead of print]
PMID: 22198569 [PubMed - as supplied by publisher]
3.
Development and characterization of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
Mulcahy P, O'Doherty A, Paucard A, O'Brien T, Kirik D, Dowd E.
Neuroscience. 2011 Dec 13. [Epub ahead of print]
PMID: 22198020 [PubMed - as supplied by publisher]
4.
Subventricular Zone Under the Neuroinflammatory Stress and Parkinson's Disease.
Mori K, Kaneko YS, Nakashima A, Nagasaki H, Nagatsu T, Nagatsu I, Ota A.
Cell Mol Neurobiol. 2011 Dec 22. [Epub ahead of print]
PMID: 22189676 [PubMed - as supplied by publisher]
Related citations
5.
Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice.
Emmer KL, Covy JP, Giasson BI.
Neurosci Lett. 2011 Dec 13. [Epub ahead of print]
PMID: 22188655 [PubMed - as supplied by publisher]
Related citations
6.
Molecular pathways in sporadic PD.
Valente EM, Arena G, Torosantucci L, Gelmetti V.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S71-3.
PMID: 22166460 [PubMed - in process]
Related citations
7.
Autosomal dominant Parkinson's disease.
Sundal C, Fujioka S, Uitti RJ, Wszolek ZK.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S7-S10.
PMID: 22166459 [PubMed - in process]
Related citations
8.
Neuronal vulnerability in Parkinson's disease.
Double KL.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S52-4.
PMID: 22166454 [PubMed - in process]
Related citations
9.
Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease.
van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW, Foncke E.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S28-30.
PMID: 22166446 [PubMed - in process]
Related citations
10.
Synucleinopathies from bench to bedside.
Puschmann A, Bhidayasiri R, Weiner WJ.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S24-7.
PMID: 22166445 [PubMed - in process]
Related citations
11.
Misfolded α-synuclein and toll-like receptors: therapeutic targets for Parkinson's disease.
Béraud D, Maguire-Zeiss KA.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S17-20.
PMID: 22166424 [PubMed - in process]
Related citations
12.
Using stem cells and iPS cells to discover new treatments for Parkinson's disease.
Cooper O, Hallett P, Isacson O.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S14-6.
PMID: 22166414 [PubMed - in process]
Related citations
13.
Vaccination for Parkinson's disease.
Schneeberger A, Mandler M, Mattner F, Schmidt W.
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S11-3.
PMID: 22166404 [PubMed - in process]
Related citations
14.
CSPα knockout causes neurodegeneration by impairing SNAP-25 function.
Sharma M, Burré J, Bronk P, Zhang Y, Xu W, Südhof TC.
EMBO J. 2011 Dec 20. doi: 10.1038/emboj.2011.467. [Epub ahead of print]
PMID: 22187053 [PubMed - as supplied by publisher]
Related citations
15.
α-Synuclein in the Skin Nerve of Pure Autonomic Failure.
Igari R, Wada M, Wakabayashi K, Kato T.
Intern Med. 2011;50(24):3049-50. Epub 2011 Dec 15. No abstract available.
PMID: 22186004 [PubMed - in process] Free Article
Related citations
16.
GSM-900MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy.
Terro F, Magnaudeix A, Crochetet M, Martin L, Bourthoumieu S, Wilson CM, Yardin C, Leveque P.
Toxicology. 2011 Dec 13. [Epub ahead of print]
PMID: 22185909 [PubMed - as supplied by publisher]
Related citations
17.
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Decressac M, Mattsson B, Lundblad M, Weikop P, Björklund A.
Neurobiol Dis. 2011 Dec 11. [Epub ahead of print]
PMID: 22182688 [PubMed - as supplied by publisher]
Related citations
18.
Transmission electron microscopy characterization of fluorescently labelled amyloid beta 1-40 and alpha-synuclein aggregates.
Anderson VL, Webb WW.
BMC Biotechnol. 2011 Dec 19;11(1):125. [Epub ahead of print]
PMID: 22182687 [PubMed - as supplied by publisher] Free Article
Related citations
19.
α-Synuclein potentiates interleukin-1β-induced CXCL10 expression in human A172 astrocytoma cells.
Tousi NS, Buck DJ, Curtis JT, Davis RL.
Neurosci Lett. 2011 Dec 13. [Epub ahead of print]
PMID: 22178859 [PubMed - as supplied by publisher]
Related citations
20.
Interaction between pathogenic proteins in neurodegenerative disorders.
Jellinger KA.
J Cell Mol Med. 2011 Dec 16. doi: 10.1111/j.1582-4934.2011.01507.x. [Epub ahead of print]
PMID: 22176890 [PubMed - as supplied by publisher]
